Gliomas are resistant to radiation therapy, as well as to TNFa induced killing. Radiation-induced TNFa triggers Nuclear factor jB (NFjB)-mediated radioresistance. As inhibition of NFjB activation sensitizes glioma cells to TNFa-induced apoptosis, we investigated whether TNFa modulates the responsiveness of glioma cells to ionizing radiation-mimetic Neocarzinostatin (NCS). TNFa enhanced the ability of NCS to induce glioma cell apoptosis. NCS-mediated death involved caspase-9 activation, reduction of mitochondrial copy number and lactate production. Death was concurrent with NFjB, Akt and Erk activation. Abrogation of Akt and NFjB activation further potentiated the death inducing ability of NCS in TNFa cotreated cells. NCS-induced p53 expression was accompanied by increase in TP53-induced glycolysis and apoptosis regulator (TIGAR) levels and ATM phosphorylation. siRNA-mediated knockdown of TIGAR abrogated NCS-induced apoptosis. While DN-IjB abrogated NCS-induced TIGAR both in the presence and absence of TNFa, TIGAR had no effect on NFjB activation. Transfection with TIGAR mutant (i) decreased apoptosis and cH2AX foci formation (ii) decreased p53 (iii) elevated ROS and (iv) increased Akt/Erk activation in cells cotreated with NCS and TNFa. Heightened TIGAR expression was observed in GBM tumors. While NCS induced ATM phosphorylation in a NFjB independent manner, ATM inhibition abrogated TIGAR and NFjB activation. Metabolic gene profiling indicated that TNFa affects NCS-mediated regulation of several genes associated with glycolysis. The existence of ATM-NFjB axis that regulate metabolic modeler TIGAR to overcome prosurvival response in NCS and TNFa cotreated cells, suggests mechanisms through which inflammation could affect resistance and adaptation to radiomimetics despite concurrent induction of death.
has been attributed to TNFa-mediated NFkB activation. 4, 5 NFkB inhibition sensitizes melanoma cells to a natural radiomimetic Neocarzinostatin (NCS)-induced apoptosis in response to aberrant TNF receptor associated factor 2 (TRAF2) signaling. 6 Radiation-induced TNFa-NFkB cross-talk promotes survival in neuroblastoma cells. 7 TNFa-mediated selection of breast cancer cells with stably acquired inducible NFkB activity, confers them resistance to irradiation or TNFa-induced killing. 8 NCS induces cell death by triggering reactive oxygen species (ROS). 9 We have previously shown that ROS sensitizes glioma cells to chemotherapeutics. 10, 11 p53 accumulates in response to ROS stress 12 and p53-induced glycolysis, and apoptosis regulator (TIGAR) protects cells from ROS-associated apoptosis. 13 Abrogation of TIGAR sensitizes glioma cells to radiation, 14 and TIGAR protects glioma cells from ROS-mediated apoptosis. 15 Importantly, TIGAR is a regulator of glycolysis, 13 and targeting key metabolic enzymes modulating glycolysis is considered a novel therapeutic approach for the highly glycolytic GBM. 16, 17 Besides, NFkB maintains balance between glycolysis and mitochondrial respiration by regulating energy metabolism networks. 18 Ataxia telangiectasia mutated (ATM) protein kinase -the master regulator of response to double-strand breaks (DSBs), links DNA damage response (DDR) and signaling events associated with proliferation and apoptosis in NCS-treated cells. 19 Also, ATM sustains NFkB activation following DNA damage. 20 As we have shown that inhibition of NFkB by chemotherapeutics sensitizes glioma cells to TNFa-induced apoptosis, 21, 22 we investigated whether TNFa effects the responsiveness of glioma cell to NCS by fine tuning the balance between survival and death through regulation of key apoptotic and metabolic network. This study forges the first link between NFkB, TIGAR and ATM in regulating responsiveness of glioma cells to radio-mimietic in the presence of proinflammatory cytokine TNFa.
Results
TNFa enhances NCS-mediated glioma cell death. To evaluate the effect of NCS on glioma cell viability, A172 and U87MG cells were treated with different concentration of NCS for 24 h. A B40% reduction in viability was observed in NCS-treated glioma cells irrespective of the dose of treatment ( Figure 1a ). As death induced by different doses of NCS was comparable (Figure 1a) , we chose 1 mg/ml of NCS for subsequent treatments. While TNFa alone had no effect on viability of glioma cells, cotreatment with NCS resulted in B50-65% decrease in viability at 24 h, as compared with control ( Figure 1b) . Thus, TNFa enhances NCS-induced glioma cell death.
NCS-mediated death involves Caspase-9 activation. As NCS-induced apoptosis in breast cancer cells involves caspase-9 activation, 23 its involvement in NCS-induced glioma cell death was investigated. Cleaved caspase-9 level was elevated in NCS-treated cells both in the presence and absence of TNFa ( Figure 1c ). As NCS-induced apoptosis involves cytochrome c 23 and as pro-apoptotic protein BAX promotes the release of cytochrome c from mitochondria, 24 the levels of BAX and cytochrome c in NCS-treated cells was determined. NCS increased BAX, BAD and cytochrome c expression both in the presence and absence of TNFa (Figure 1c ). To further confirm the role of caspase-9 in NCS-mediated death, viability of cells treated with different combinations of TNFa and NCS in the presence and absence of caspase-9 inhibitor was determined. The ability of caspase-9 inhibitor to revert the cytotoxic effect of NCS indicated the involvement of caspase-9 in NCS-mediated apoptosis (Figure 1d ).
NCS disrupts mitochondrial morphology and decreases ATP generation. As elevated cytochrome c in NCS-treated cells is suggestive of mitochondrial dysfunction, MitoTracker green staining, which allows visualization of healthy functional mitochondria was performed. NCS disrupted mitochondrial morphology both in the presence and absence of TNFa (Figure 1e ). Mitochondrial oxidation is one of the key mitochondrial functions involved in ATP synthesis. As NCS-induced glioma cell death involved mitochondria, ATP levels in NCS-treated cells was determined. The B20% decrease in ATP generation observed in NCS-treated cells was further reduced by 40-50% in the presence of TNFa. Thus, NCS-mediated decrease in energy homeostasis is heightened in the presence of TNFa (Figure 1f ).
NCS decreases lactate accumulation. Elevated lactate levels contribute to radioresistance. 25 As lactate is an important contributor to ATP generation in astrocytoma cells, 26 lactate levels in NCS-treated cells with diminished ATP levels were determined. NCS decreased lactate production both in the presence and absence of TNFa (Figure 1g ).
NCS-mediated
enhanced NFjB activation in TNFa-treated cells confers prosurvival advantage. NFkB is activated by ionizing radiation. 1 Besides, NFkB regulates mitochondrial respiration and has a role in metabolic adaptation in cancer. 18 As NCS-induced glioma cell death involved mitochondria, the status of NFkB activity in NCS-treated cells was determined. Though NCS had no significant effect on NFkB activity, it significantly enhanced TNFa mediated increase in NFkB transcriptional activity (Figure 2a) . Thus, NCS-potentiated TNFa induced aberrant NFkB activation in glioma cells.
We have shown that chemotherapeutics mediated abrogation of TNFa induced NFkB activation, sensitizes glioma cell to TNFa induced apoptosis. 21, 22 To explain the incongruity of increased NFkB activation in cells undergoing death, the ability of NCS to induce death in cells transfected with IkBM was investigated. While transfection with IkBM increased NCS-induced death, this increase was significantly greater in cells cotreated with NCS and TNFa. This indicated that inhibition of NFkB activation increases sensitivity of glioma cells to NCS induced death in the presence of TNFa (Figure 2b ).
NCS increases Akt and Erk phosphorylation. Akt activates NFkB to suppress apoptosis 27 and inhibition of mitochondrial respiration induces Akt activation. 28 Coactivation and mutual dependence of ERK and NFkB enhances cell survival after irradiation exposure. 29 As NCS-induced disruption of mitochondrial integrity was accompanied by elevated NFkB activation, the effect of NCS on Akt and Erk activation was investigated. NCS and TNFa cotreatment Activated Akt is associated with prosurvival responses in glioma. To establish the functional significance of this increased Akt activation in NCS and TNFa cotreated cells undergoing death, the viability of these cells in the presence of Akt inhibitor LY294002 was determined. Though inhibition of Akt resulted in increased sensitization of glioma cells to NCSmediated cell death, sensitization was significantly greater in the presence of TNFa (Figure 2d ). This suggests that aberrant Akt activation prevents the maximal induction of cell death by NCS (Figure 2d ).
Increased p53 expression and ROS generation in NCStreated cells. NFkB cooperates with p53 to regulate bioenergetic pathway controlling adaptation to metabolic stress. 18 As NFkB-p53 cross-talk affect tumor-associated metabolic changes and transformation, 30 p53 status in NCS and TNFa cotreated cells with heightened NFkB activation was determined. NCS increased p53 phosphorylation (Ser-15), as well as total p53 level both in the presence and absence of TNFa (Figure 3a ). p53 accumulation in response to ROS facilitates cellular responses to ROS-induced DNA damage. 12 As NCS-mediated ROS induces cell death 9 Figure 1a) . The ability of ROS inhibitor NAC to abrogate NCS-induced cytotoxicity, both in the presence and absence of TNFa, suggested that NCS-induced cell death is ROS dependent (Supplementary Figure 1b) .
the status of ROS in NCS-treated cells was determined. NCS elevated ROS generation in glioma cells (Supplementary
NCS elevates TIGAR levels in the presence and absence of TNFa. By simultaneously regulating glycolysis, apoptosis and ROS generation, TIGAR regulates oxidative mitochondrial metabolism. 13 p53 not only induces apoptosis but by activating TIGAR it also contributes to metabolic abnormalities. 31 Besides, knockdown of TIGAR radiosensitizes glioma cells.
14 In silico analysis Oncomine based on cancer microarray database and integrated data-mining platform indicated elevated TIGAR in GBM. 15 On investigating the status of TIGAR in GBM tumors, heightened TIGAR expression was observed in glioma tumors as compared with the surrounding normal tissue ( Figure 3b ). As NCSinduced glioma cell death involves mitochondrial dysfunction, elevated ROS and p53 activation; the status of TIGAR in these cells was investigated. While TIGAR levels in control and TNFa-treated cells were comparable (Figure 3c ), NCS elevated TIGAR levels both in the presence and absence of TNFa ( Figure 3c ).
TIGAR regulates NCS-mediated cell death. TIGAR modulates the apoptotic responses to p53. 13 To investigate the functional significance of increased TIGAR levels in regulating apoptosis in NCS-treated cells with elevated p53 levels, the viability of NCS-treated glioma cells transfected with TIGAR siRNA was determined. NCS induced cell death both in the presence and absence of TNFa was significantly reduced upon siRNA-mediated knockdown of TIGAR ( Figure 4a ). Decrease in TIGAR expression reduced the sensitivity of glioma cells to NCS-induced apoptosis.
Functioning in a manner similar to FBPase-2, TIGAR lowers Fru-2, 6-P2 levels thereby decreasing the activity of phosphofructokinase-1 (PFK-1) and enhancing the activity of FBPase-1, to subsequently inhibit glycolysis. 13 As decreased glycolysis enhances cell death by apoptosis, 32 we further investigated the role of TIGAR in sensitizing glioma cells to NCS-induced death in the backdrop of its ability to regulate glycolysis. The viability of cells transfected with TIGAR-WT or TIGAR-TM (altered in the key residues essential for bisphosphatase activity), and treated with different combinations of NCS and TNFa was determined. Though silencing of TIGAR induces glioma cell apoptosis, 14 we failed to observe any significant change in glioma cell viability upon transfection with either TIGAR-WT or TIGAR-TM. It is possible that the cell context determines response of TIGAR to different stimuli.
While transfection with TIGAR-WT increased NCS-induced death by B10-15% (Figure 4b ), transfection with TIGAR-TM abrogated NCS-mediated cell death both in the presence and absence of TNFa (Figure 4b ). An B80% inhibition of NCS-induced death was observed in cells transfected with TIGAR-TM. On the other hand, TIGAR-WT or TM had no effect on the viability of cells in the absence of NCS or TNFa. Though TIGAR-TM exhibits impaired anti-apoptotic activity, 13 its effect on cell survival is known to be both cell and context dependent. 13 Along with TIGAR siRNA results, ability of TIGAR-TM to abrogate NCS-induced death indicated the involvement of TIGAR in sensitizing glioma cells to NCS-mediated apoptosis.
TIGAR regulates intracellular ROS levels in NCS-treated cells. As TIGAR protect cells from ROS-associated apoptosis, 13 we investigated whether TIGAR regulates intracellular ROS to effect NCS-induced apoptosis. Transfection of U87MG cells with TIGAR-TM increased ROS in NCS-treated cells both in the presence and absence of TNFa (Figure 4c ). Similar results were observed with A172 (data not shown). This indicated that elevated TIGAR protects glioma cells from NCS-and TNFa-induced ROS.
NCS has no effect on LC3-II expression. Induction of autophagy upon loss of TIGAR moderates apoptotic response by restraining ROS levels. 33 To explain the paradox between enhanced ROS levels and increased survival in TIGAR-TM-transfected cells despite NCS mediated death being ROS dependent, the expression of autophagic marker LC3-II in TIGAR-TM-transfected cells treated with NCS was determined. Conversion of LC3-I to LC3-II which indicates induction of autophagy, 34 remained unaffected in NCS-treated cells both in the presence and absence of TNFa. NCS-induced glioma cell death does not involve autophagy, as LC3-II expression in NCS-treated cells between mock transfected and TIGAR-TM-transfected cells were comparable (Figure 4d ).
NFjB regulates NCS-induced TIGAR expression but Akt has no effect. To explain the dichotomy of coexistence of While transfection with IkBM decreased TIGAR levels in NCS-treated cells both in the presence and absence of TNFa, the decrease was greater in cells cotreated with NCS and TNFa. However, NFkB inhibition had no effect on basal TIGAR levels in untreated or TNFa-treated cells (Figure 5a ). On the other hand, Akt inhibition had no effect on NCS-induced TIGAR levels both in the presence and absence of TNFa (Figure 5a ).
TIGAR regulates Akt and Erk phosphorylation but has no effect on NFjB activation in NCS-treated cells. The ability of TIGAR-TM to inhibit the apoptotic ability of NCS, prompted us to investigate its role in regulating Akt and Erk activation. Transfection with TIGAR-TM further elevated NCS-induced antiapoptotic regulator Akt and Erk (Figure 5b ). This could possibly account for reversal of NCS-mediated death in TIGAR-TM transfected cell despite an increase in proapoptotic ROS. As NFkB positively regulates TIGAR in cells cotreated with NCS and TNFa, we questioned whether TIGAR is involved in sustaining elevated NFkB in these cells. The ability of NCS to increase TNFa-induced NFkB activation remained unaffected in cells transfected with TIGAR-TM (Figure 5c ). Therefore, increase in TNFa-induced NFkB activation in NCS-treated cells is independent of TIGAR.
TIGAR affects p53 and its target gene p21 in NCS-treated cells. NCS induced increase in p53 and its target p21 levels, both in the presence and absence of TNFa, and was abrogated in cells transfected upon with TIGAR-TM. This decrease in p53 correlated with TIGAR-TM mediated reversal of NCS-induced apoptosis (Figure 5d ).
NCS-induced ATM phosphorylation regulates NFjB activation in TNFa-treated cells. Activation of ATM in response to ionizing radiation is Akt dependent. 35 As ATM elicits DDR (DNA damage response) that confers radioresistance in glioma, 36 we determined ATM status in NCStreated cells with elevated Akt levels. NCS increased ATM phosphorylation both in the absence and presence of TNFa (Figure 6a ). ATM regulates NFkB in response to genotoxic stress. 37 As increased ATM phosphorylation in NCS and TNFa cotreated cells is concurrent with elevated NFkB activation, the effect of ATM inhibition on NFkB activation was determined. NFkB activation in TNFa-treated cells both in the presence and absence of NCS was abrogated by ATM inhibitor (Figure 6b ). This supports previous findings that Figures (a, b and d) representative blot shown from three independent experiments with identical results. Blots were reprobed with b-actin to establish equivalent loading ATM sustains NFkB activation. 20 However, NCS-induced ATM activation occurs independently of NFkB; as pATM levels in NCS-treated cells both in the presence and absence of TNFa were comparable between mock and IkBMtransfected cells (Figure 6c ).
TNFa affects the ability of ATM to regulate TIGAR. As our findings suggest that ATM regulates NFkB, and as NFkB regulates NCS-induced TIGAR, the role of ATM in regulating TIGAR was investigated. ATM inhibition abrogated TIGAR levels in cells cotreated with NCS and TNFa (Figure 6d) , suggesting that the ability of ATM to regulate TIGAR is modulated by TNFa.
NCS decreases mitochondrial copy number in an ATM independent manner. Reduction of the mitochondrial genome content induces Erk and Akt activation, 38 and ATM is involved in mitochondrial homeostasis. 39 As NCS-mediated death involved mitochondria and aberrant Erk/Akt activation, the effect of NCS-induced ATM phosphorylation on mitochondrial copy number was determined. Mitochondrial genome copy number/cell was significantly reduced upon NCS treatment both in the presence and absence of TNFa (Figure 6e ). The ability of ATM inhibitor to revert NCS-mediated decrease in mitochondrial copy number both in the presence and absence of TNFa was not significant (Figure 6e) . TIGAR regulates DDR. ATM activated in response to DSBs phosphorylates H2AX. 40 gH2AX formation in the chromatin surrounding DSBs can be visualized as discrete nuclear foci. 41 Moreover, NCS-induced ROS induction is partly mediated by increasing gH2AX.
9 As NCS-induced TIGAR induction is ATM dependent and is accompanied by elevated ROS, gH2AX levels in cells transfected with TIGAR-TM and treated with different combinations of NCS and TNFa were determined. NCS increased gH2AX in the presence and absence of TNFa.This increase in gH2AX was TIGAR dependent, as elevated gH2AX levels were abrogated to control levels in TIGAR-TM-transfected cells (Figure 7a) . Also, increased gH2AX foci formation seen in NCS-treated NCS regulates genes associated with glucose metabolism. NCS-induced decreased lactate production was accompanied by increased TIGAR, which is a known p53 inducible regulator of glycolysis. As decreased lactate production and elevated TIGAR levels in NCS-treated cells suggested an altered metabolic state, the status of genes associated with glucose metabolism was analyzed in (Table 1 ). An increase in Fructose-1, 6 bisphosphatase (FBPase-1 and 2) levels in NCS-treated cells both in the presence and absence of TNFa was observed. This was interesting as FBPase-2 lowers fructose-2,6-bisphosphatean inhibitor of fructose-1,6-bisphosphatase (FBPase-1), thereby enhancing the activity of FBPase-1 to inhibit glycolysis. Also, the decreased level of Hexokinase 2 (HK2), which regulates aerobic glycolysis and is involved in glioma progression, 16 suggested altered glycolysis in NCS-treated cells both in the presence and absence of TNFa (Table 1) .
Discussion
The ability of radiation induced NFkB-TNFa-NFkB positive feed forward cycle to facilitate radioprotection and survival advantage, links NFkB-TNFa cross-talk to resistance and relapse of neuroblastoma following radiation therapy. 7 While radiotherapy is the mainstay of GBM treatment; survival and adaptation of cells that escape death following radiotherapy is essential for glioma promotion and progression. Constitutive activation of NFkB in GBM facilitates tumorigenesis. 42 As inhibition of NFkB activation sensitizes glioma cells to TNFa-induced apoptosis, 21, 22 we investigated whether TNFa could affect the responsiveness of glioma cells to radiomimetics such as NCS. Though TNFa enhanced NCS-induced glioma cell death, the response of cells to radiomimetic NCS in the presence of TNFa is paradoxical as the activation of NFkB and Akt/Erk associated with prosurvival response is concurrent with apoptosis. Enhanced apoptosis in NCS and TNFa cotreated cells upon NFkB inhibition, indicates that NCS-induced NFkB enhances cell survival to subsequently limit its therapeutic potential; as reported previously with radiation therapy. 7 This ability of NCS-induced prosurvival NFkB and Akt to prevent manifestation of the death inducing ability of NCS to the fullest, could possibly account for the non-linear dose-dependent response of glioma cells to NCS.
NCS-induced proapoptotic TIGAR is dependent on NFkB activation and this dependence is further heightened in the presence of proinflammatory TNFa. As elevated NFkB and Akt activation maximizes survival of NCS-treated cells, increase in TIGAR possibly occurs to counteract these prosurvival signals. Though Akt activation leads to Warburg effect, high Akt activity can also render cells sensitive to death induced by glycolysis inhibitor. 43 NCS-induced Akt activation could possibly sensitize glioma cells to TIGAR -an inhibitor of glycolysis. NFkB promotes metabolic adaptation in cancer, 18 and p53 prevents NFkB activation through suppression of glycolysis. 44 Although NFkB activation in TNFa and NCS cotreated cells is TIGAR independent, p53 induction in these cells is regulated by TIGAR. It is possible that TIGARdependent p53 regulates NFkB activation through suppression of glycolysis, Taken together, it is the fine tuning between pro-and antiapoptotic responses (TIGAR versus Akt/NFkB), that enable glioma cells to withstand radiomimetic-induced stress and acquire radioresistance or undergo death. DSB (double-strand breaks) trigger ATM-and Akt-dependent Erk prosurvival signal, 45 and ATM/ERK/NFkB prosurvival network induces radio-adaptive response in human keratinocytes. 46 The ability of NCS-induced ATM to regulate NFkB in glioma cells exposed to radiomimetics, agrees with previous reports that ATM inhibition radiosensitizes glioma cells. 36 This coupled with ATM-NFkB axis driven TIGAR to regulate Akt/Erk activation negatively and gH2AX activation positively, suggests that a feedback regulatory mechanism functions as a rheostat to affect radiomimetic-induced adaptive responses (Figure 8) . Previous studies have shown that irradiation induced TGF-b signaling triggers complicated negative feedback regulation to affect irradiation induced adaptive responses, genomic instability and bystander effects. 47 Though NFkB can affect the death inducing potential of NCS via regulation of proapoptotic TIGAR; its own prosurvival and cytoprotective ability under such conditions can concurrently dampen TIGAR-induced cell death. Cells that survive radiation-induced injury contribute to glioma radioresistance through increase in DNA repair capacity. 48 Importantly, acquisition of proinflammatory cytokine inducible NFkB activity in TNFa selected breast cancer cells, promotes resistance to irradiation without affecting transformation. 8 It is tempting to speculate that increased NFkB activation in Abbreviation: NCS, neocarzinostatin; TNFa, tumor necrosis factor-a. Gene expression profiling of mRNA isolated from U87MG-glioma cells treated with TNFa in the presence and absence of NCS, was analyzed by qRT-PCR for genes involved in glucose metabolism. Expressions of several genes affected by the treatments are shown. Table represents the average data from two independent experiments.
ATM-NFjB axis regulates TIGAR S Sinha et al cells that survives in the NCS-TNFa milieu could contribute to tumor recurrence with a resistant phenotype. ATM stimulates pentose phosphate pathway (PPP) to induce anti-oxidant defense, and ATM-mediated inhibition of glycolysis has been suggested to reduce ROS, generated through glycolytic metabolism. 49 As TIGAR activates PPP, 13 ATM-driven TIGAR could regulate redox homeostasis in NCS-treated cells by preventing excessive ROS generation. p53 protects genome from oxidative damage by decreasing ROS levels 50 and NCS-induced p53 and ROS is regulated by TIGAR. Misrepair of radiation-induced DSBs can be mutagenic. By functioning as sensor that detects DNA damage, TIGAR likely protects cells from ROS-associated DNA damage that could lead to genomic instability. The simultaneous increase in antiapoptotic Akt and proapoptotic ROS in cells transfected with TIGAR-TM, is concurrent with its ability to rescue cells from NCS-induced death. This dichotomous behavior of TIGAR-TM coupled with its ability to decrease both p53 and p21 levels, could possibly account for reversal of NCS-mediated death in TIGAR-TM-transfected cells despite elevated ROS generation.
NFkB represses mitochondrial gene expression following TNFa stimulation 51 and mitochondrial dysfunction is associated with apoptosis. 52 NCS-induced decreased mitochondrial copy number and loss of mitochondrial integrity could have also resulted in increased Akt activation, as mitochondrial DNA deletion increases NADH-dependent Akt activation that contributes to drug resistance. 28 Increased FBPase-1 and 2 levels concurrent with elevated TIGAR indicated altered glycolysis in NCS-treated cells. As cancer cells use increased glycolysis to generate ATP as main energy source, 53 abrogated ATP generation in NCS-treated cells was concomitant with decreased glycolysis. TNFa also affected NCSmediated regulation of several genes associated with glucose metabolism such as Aldolase C, Phospho-enolpyruvate carboxykinase 1, Pyruvate dehydrogenase kinase and Phosphorylase kinase.
Through simultaneous regulation of cytoprotective NFkB and pro-apoptotic TIGAR, ATM balances resistance versus sensitivity to radiomimetics. Here we demonstrate the importance of ATM-NFkB axis in regulating responsiveness of glioma cells to radiomimetic through metabolic modeler TIGAR in a proinflammatory milieu. Given that metabolic modulation holds promise as a potential antiglioma therapeutic approach, 17 understanding mechanisms of TIGAR regulation to subsequently sensitize glioma cells to apoptosis warrants investigation. As glioma cells that escape NCS-induced death could acquire concurrent adaptation and survival advantage through NFkB and Akt/Erk activation; further investigation of this complex regulation of pro/ antisurvival mediators and metabolic remodeling following exposure to radiomimetics, would lead to better understanding of radioresistance and open avenues for improving efficacy of glioma radiotherapy.
Materials and Methods
Processing of tissue and Immunohistochemistry. Immunohistochemistry was performed on histologically confirmed GBM (n ¼ 21) to determine TIGAR expression as described. 54 Non-neoplastic brain tissue (n ¼ 8) from margins of the tumors was used as control. Samples were obtained as per the guidelines of Institutional Human Ethics Committee of NBRC.
Cell culture and treatment. Glioblastoma cell lines A172 and U87MG obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) were cultured in DMEM supplemented with 10% fetal bovine serum. On attaining semi-confluence, cells were switched to serum free media (SFM) and after 12 h, cells were treated with different combinations of NCS (Sigma, St. Louis, MO, USA) and TNFa (R&D Systems, Minneapolis, MN, USA; 50 ng/ml) in the presence and absence of Caspase-9 inhibitor (Calbiochem, Merck KGaA, Darmstadt, Germany), or AKT inhibitor LY294002 or ATM inhibitor KU60019 (Tocris Bioscience, Northpoint, UK) for 24 h. All reagents were purchased from Sigma unless otherwise stated.
Determination of cell viability. Viability of glioma cells treated with different combinations of TNFa and NCS in the presence and absence of 50 mM Caspase-9 inhibitor or 10 mM LY294002 or 5 mM KU60019, for 24 h was assessed using the MTS assay (Promega, Madison, WI, USA) as described. 22 Similarly, the viability of cells transfected with TIGAR siRNA (40 nM), TIGAR-WT or TIGAR-TM and treated with TNFa or NCS or both for 24 h was assessed using the MTS assay as described. 22 Values were expressed as a percentage relative to those obtained in controls.
Western blot analysis. Protein was isolated from cells treated with different combinations of TNFa, NCS, LY294002 and KU60019, and western blot was performed as described. 55 The following antibodies were used -p53, p p53 ser-15, p21 (BD Biosciences, San Diego, CA, USA), BAX, BAD, Cytochrome c, Caspase-9 (Abcam, Cambridge, UK), gH2AX (Ser 139) (Upstate, Millipore, Temecula, CA, USA), TIGAR (Novus, Cambridge science Park, Cambridge, UK), ATM and pATM. LC3-I/II, Akt, pAkt, Erk, pErk were obtained from Cell Signaling (Danvers, MA, USA). Antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) unless otherwise mentioned. Secondary antibodies were purchased from Vector Laboratories (Burlingame, CA, USA). The blots were stripped and reprobed with anti-b-actin (Sigma) to determine equivalent loading as described. 55 Transfections and luciferase assay. Reporter assay was performed in cells transfected with NFkB luciferase reporter alone or cotransfected with TIGAR-TM construct and treated with different combinations of TNFa, NCS and KU60019, as described previously. 54 In experiments with TIGAR-TM and DN-NFkB (IkBM), control transfection using the appropriate empty vector construct was performed as described. 22 For siRNA-mediated knockdown experiment, cells were transfected with 40 nmol/l TIGAR or non-specific siRNA (Dharmacon, Thermo Fischer Scientific, Lafayette, CO, USA) using Lipofectamine RNAi Max reagent (Life Technologies-Invitrogen, Carlsbad, CA, USA) as described. 22 Western blot was performed on protein isolated from cells transfected with TIGAR-TM or IkBM and treated with different combinations of TNFa and NCS for 24 h as described. 55 The NFkB luciferase reporter and DN-NFkB (IkBM) were purchased from Clontech (Madison, WI, USA). We thank Karen Vousden for providing Figure 8 Proposed model demonstrating the regulation of TIGAR and its role in the responsiveness of glioma cells to radiomimetics in the presence of TNFa. NCS induces TIGAR in an ATM-and NFkB-dependent manner. NCS-mediated glioma cell death is ROS dependent and TIGAR regulates ROS generation in addition to Akt/Erk activation and gH2AX foci formation. NCS-induced alteration in genes associated with glycolysis is affected by the presence of TNFa. FBP, Fructose Bisphosphatase 2; HK2, Hexokinase 2; PDK, Pyruvate dehydrogenase kinase the pcdna3.1FLAG-TIGAR and pcdna3.1FLAG-TIGAR-TM mutant expression plasmids. 13 TIGAR-TM is a triple mutant, altered in three key residues essential for bisphosphatase activity. 13 Measurement of intracellular ATP. Intracellular ATP levels were measured by luminometric assay using the ATPlite, Luninescence ATP detection assay system (Perkin Elmer, Waltham, MA, USA) according to the manufacturer's instructions. Briefly, cells treated with different combination of TNFa and NCS for 24 h in 96-well plates were lysed with 50 ml of mammalian cell lysis solution, incubated with 50 ml substrate solution (Luciferase/luciferin) for 10 min in dark, and luminescence was measured (Glomax luminometer, Promega). Values were expressed as a percentage relative to those obtained in controls.
Lactate measurement. Lactate release in the supernatant collected from cells treated with different combinations of NCS and TNFa for 24 h, was measured with a Lactate Colorimetric Assay Kit (Biovision Inc. Milpitas Blvd, CA, USA), according to the manufacturer's indication. Briefly, 5 ml of supernatant was incubated with reaction mix containing lactate assay buffer, lactate probe and lactate enzyme mix for 30 min in dark. OD was measured at 570 nm, and concentration of lactate (nmol/ml) was measured using standard curve.
qRT-PCR of the mitochondrial genome content. The mitochondrial Novaquant human mitochondrial to nuclear DNA ratio kit genome content was used for determining mtDNA copy number according to manufacturer's instructions (NovaQUANT, Merck KGaA). Briefly, genomic DNA isolated from test samples were mixed with qRT-PCR master mix and plated on provided qRT-PCR plate containing a set of four optimized PCR primer pairs targeting two nuclear and two mitochondrial genes. Resultant C t values obtained from RT-PCR were used to represent mtDNA copy number per cell by comparing nuclear genes to the corresponding mitochondrial genes.
Immunofluorescence. Following treatment with NCS in the presence and absence of TNFa for 24 h, cells were fixed in 4% paraformaldehyde. Fixed cells were incubated with anti-gH2AX antibody overnight at 4 1C, washed and further incubated with Alexa Fluor 488 (Invitrogen) secondary antibody for 2 h at room temperature. The expression of gH2AX (green) was analyzed using Zeiss ApoTome Imager.Z1 as described. 56 DNA counterstaining was performed with 4,6-diamidino-2-phenylindole (DAPI) (Vector).
For MitoTracker Green FM (Invitrogen) staining, cells treated with NCS or TNFa or both in SFM for 24 h were incubated with 500 nM of Mitotracker probe prepared in prewarmed (37 1C) SFM and incubated for 45 min at 37 1C. After incubation, staining media was replaced with fresh prewarm PBS and images were taken under fluorescence microscope.
Measurement of ROS. Intracellular ROS generation was assessed using fluorescent dye dihydroethidium (DHE, Sigma) as described. 11 For detection with DHE, mock and TIGAR-TM transfected cells treated with different combination of NCS and TNFa for 24 h were loaded with 1 mM DHE at 37 1C for 20 min and images ware captured by Nikon Eclipse TS100 (Nikon Instruments Inc., Melville, NY, USA) fluorescence microscope using a Rhodamine filter.
Human metabolism qRT-PCR array. qRT-PCR was performed using The Human Glucose Metabolism RT2 Profiler containing 84 metabolism-related genes (Qiagen, Hilden, Germany) as described previously. 22 Five housekeeping genes were included on the array (B2M, HPRT1, RPL13A, GAPDH and ACTB) to normalize the transcript levels. Results were analyzed as per user manual guidelines using integrated web-based software package for the PCR Array System (RT2 Profiler PCR Array Human Glucose Metabolism PAHS-006Z).
Statistical analysis. All comparisons between groups were performed using two-tailed paired student's t-test. All P-values o0.05 were taken as significant.
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